PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Jasper Therapeutics, Inc.
Filed: April 10, 2023
Period of Report: April 10, 2023
Accession Number: 0001213900-23-028579

View Document ↗ View on SEC.gov ↗